Clonal heterogeneity and tumor evolution: past, present, and the future

McGranahan, Nicholas, Swanton, Charles·2017·Cell
DOI 10.1016/j.cell.2017.01.018

Cited by (128)

Items 101–128 of 128

  1. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
    Heymann, Marie-Françoise, Lézot, Frédéric, Heymann, Dominique · 2019 · Cellular Immunology
  2. Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
    Boshuizen, Julia, Koopman, Louise A, Krijgsman, Oscar, Shahrabi, Aida, van den Heuvel, Elke Gresnigt–, Ligtenberg, Maarten A, Vredevoogd, David W, Kemper, Kristel, Kuilman, Thomas, Song, Ji-Ying et al. · 2018 · Nature Medicine
  3. Emerging organoid models: leaping forward in cancer research
    Fan, Han, Demirci, Utkan, Chen, Pu · 2019 · Journal of Hematology & Oncology
  4. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
    Sadida, Hana Q., Abdulla, Alanoud, Marzooqi, Sara Al, Hashem, Sheema, Macha, Muzafar A., Akil, Ammira S. Al-Shabeeb, Bhat, Ajaz A. · 2024 · Translational Oncology
  5. Radiotheranostics in oncology: Making precision medicine possible
    Aboagye, Eric O., Barwick, Tara D., Haberkorn, Uwe · 2023 · CA: A Cancer Journal for Clinicians
  6. Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF
    Blasco, María Teresa, Navas, Carolina, Martín-Serrano, Guillermo, Graña-Castro, Osvaldo, Lechuga, Carmen G., Martín-Díaz, Laura, Djurec, Magdolna, Li, Jing, Morales-Cacho, Lucia, Esteban-Burgos, Laura et al. · 2019 · Cancer Cell
  7. Large Scale Foundation Model on Single-cell Transcriptomics
    Hao, Minsheng, Gong, Jing, Zeng, Xin, Liu, Chiming, Guo, Yucheng, Cheng, Xingyi, Wang, Taifeng, Ma, Jianzhu, Song, Le, Zhang, Xuegong · 2023
  8. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches
    Truong, Linh-Huyen, Pauklin, Siim · 2021 · Cancers
  9. Engineering chimeric antigen receptor-T cells for cancer treatment
    Ye, Baixin, Stary, Creed M., Li, Xuejun, Gao, Qingping, Kang, Chunsheng, Xiong, Xiaoxing · 2018 · Molecular Cancer
  10. Into the multiverse: advances in single-cell multiomic profiling
    Ogbeide, Silvia, Giannese, Francesca, Mincarelli, Laura, Macaulay, Iain C. · 2022 · Trends in Genetics
  11. Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma
    Zheng, Chunxing, Snow, Bryan E., Elia, Andrew J., Nechanitzky, Robert, Dominguez-Brauer, Carmen, Liu, Shaofeng, Tong, Yin, Cox, Maureen A., Focaccia, Enrico, Wakeham, Andrew C. et al. · 2023 · Nature Cancer
  12. Intratumor CMS heterogeneity impacts patient prognosis in localized colon cancer
    Marisa, Laetitia, Blum, Yuna, Taieb, Julien, Ayadi, Mira, Pilati, Camilla, Le Malicot, Karine, Lepage, Côme, Salazar, Ramon, Aust, Daniela, Duval, Alex et al. · 2021 · Clinical Cancer Research
  13. Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures
    Suphavilai, Chayaporn, Chia, Shumei, Sharma, Ankur, Tu, Lorna, Da Silva, Rafael Peres, Mongia, Aanchal, DasGupta, Ramanuj, Nagarajan, Niranjan · 2021 · Genome Medicine
  14. <i>IDH</i> Mutation Subgroup Status Associates with Intratumor Heterogeneity and the Tumor Microenvironment in Intrahepatic Cholangiocarcinoma
    Xiang, Xiao, Liu, Ziyang, Zhang, Chong, Li, Zhao, Gao, Jie, Zhang, Changkun, Cao, Qi, Cheng, Jinghui, Liu, Hengkang, Chen, Dingbao et al. · 2021 · Advanced Science
  15. Cell Fate Reprogramming in the Era of Cancer Immunotherapy
    Zimmermannova, Olga, Caiado, Inês, Ferreira, Alexandra G., Pereira, Carlos-Filipe · 2021 · Frontiers in Immunology
  16. Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy
    Sparks, Hugh, Kondo, Hiroshi, Hooper, Steven, Munro, Ian, Kennedy, Gordon, Dunsby, Christopher, French, Paul, Sahai, Erik · 2018 · Nature Communications
  17. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer
    Li, Junyu, Li, Lin, You, Peimeng, Wei, Yiping, Xu, Bin · 2023 · Seminars in Cancer Biology
  18. Immune checkpoint inhibitors for multiple myeloma immunotherapy
    Liu, Zhaoyun, Xu, Xintong, Liu, Hui, Zhao, Xianghong, Yang, Chun, Fu, Rong · 2023 · Experimental Hematology &amp; Oncology
  19. Network approach in liquidomics landscape
    Santini, Daniele, Botticelli, Andrea, Galvano, Antonio, Iuliani, Michele, Incorvaia, Lorena, Gristina, Valerio, Taffon, Chiara, Foderaro, Simone, Paccagnella, Elisa, Simonetti, Sonia et al. · 2023 · Journal of Experimental &amp; Clinical Cancer Research
  20. Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution
    Sepich‐Poore, Gregory D., Guccione, Caitlin, Laplane, Lucie, Pradeu, Thomas, Curtius, Kit, Knight, Rob · 2022 · BioEssays
  21. Role of tumor-informed personalized circulating tumor DNA assay in informing recurrence in patients with peritoneal metastases from colorectal and high-grade appendix cancer undergoing curative-intent surgery
    Dhiman, Ankit, Kothary, Vishesh, Witmer, Hunter D. D., Bregio, Celyn, Sood, Divya, Ong, Cecilia T., Polite, Blase, Eng, Oliver S., Shergill, Ardaman, Turaga, Kiran K. · 2023 · Annals of Surgery
  22. Dynamic MAPK signaling activity underlies a transition from growth arrest to proliferation in <i>Drosophila scribble</i> mutant tumors
    Ji, Tiantian, Zhang, Lina, Deng, Mingxi, Huang, Shengshuo, Wang, Ying, Pham, Tri Thanh, Smith, Andrew Alan, Sridhar, Varun, Cabernard, Clemens, Wang, Jiguang et al. · 2019 · Disease Models &amp; Mechanisms
  23. A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
    Seligson, Nathan D, Chen, James L, Goodrich, Austin C, Van Tine, Brian A, Campbell, Jordan D, Richards, Allison L, Antonescu, Cristina R, Liebner, David A, Milhem, Mohammed M, Streicher, Howard et al. · 2024 · Journal for ImmunoTherapy of Cancer
  24. In situ metabolic Characterisation of Breast Cancer and its Potential Impact on Therapy
    Petővári, Gábor, Dankó, Titanilla, Tőkés, Anna-Mária, Vetlényi, Enikő, Krencz, Ildikó, Raffay, Regina, Hajdu, Melinda, Sztankovics, Dániel, Németh, Krisztina, Vellai-Takács, Krisztina et al. · 2020 · Cancers
  25. Spatial Transcriptomics Unveils Regional Heterogeneity and Subclonal Dynamics in the Lung Adenocarcinoma Microenvironment
    An, Haoyuan, Fang, Wei, Chen, Haiyan, Huang, Weiying, Liu, Hongbin, Zhang, Zhenlei, Zhao, Hanzhu, Zhang, Yanbing, Zhao, Miaoqing, Qiu, Jianfeng et al. · 2025 · Computer Methods and Programs in Biomedicine
  26. Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective
    Yuan, Zixuan, Liu, Zhiwei, Zhou, Mengying, Wen, Huijuan, Li, Bei · 2026 · Critical Reviews in Oncology/Hematology
  27. Effective Treatment With Afatinib of Lung Adenocarcinoma With Leptomeningeal Metastasis Harboring the Exon 18 p.G719A Mutation in the EGFR Gene Was Detected in Cerebrospinal Fluid: A Case Report
    Ma, Chunhua, Wang, Shuyuan, Mu, Ning, Li, Jinduo, Liu, Mei, Li, Lin, Jiang, Rong · 2020 · Frontiers in Oncology
  28. Liver Resection after Disease Control with Abemaciclib for Solitary Liver Metastasis from Breast Cancer: A Case Report
    Kurokawa, Yuki, Terakawa, Hirofumi, Mohri, Ryosuke, Hirata, Miki, Gabata, Ryosuke, Yagi, Shintaro, Inaki, Noriyuki · 2026 · Surgical case reports